Yüklüyor......
SGLT2 Inhibitors Through the Windows of EMPA-REG and CANVAS Trials: A Review
EMPA-REG OUTCOME and CANVAS trials were designed to study the cardiovascular safety of empagliflozin and canagliflozin, respectively. Both studies were sufficiently powered to study the non-inferiority for cardiovascular (CV) outcomes in patients with type 2 diabetes mellitus (DM) and showed superio...
Kaydedildi:
| Yayımlandı: | Diabetes Ther |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Healthcare
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5688986/ https://ncbi.nlm.nih.gov/pubmed/29076040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0320-1 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|